University of Kentucky researchers led by Dr. Jayakrishna Ambati, professor and vice-chair in the Department of Ophthalmology and Visual Sciences at the University of Kentucky, have made revealing discoveries about the precise mechanisms of retinal pigmented epithelium (RPE) death in the late stages of age-related macular degeneration (AMD). The findings were released last week in the Proceedings in the National Academy of Sciences (PNAS).
Geographic atrophy, an advanced form of dry AMD characterized by death of the RPE, causes untreatable blindness in millions worldwide.
A team from The University of Kentucky's Neurosurgery Residents program placed second in their first year of competition at The Congress of Neurological Surgery Resident Academic Competition. Dr. Steven Grupke and Dr. Farhan Mirza were the two residents selected for the team.
The live competition, which was held at the annual congress in Boston in Oct. 15-22, featured the top nine teams from an initial pool of 105 neurosurgery resident programs from the United States and Canada.
In 2014, ºÃÉ«ÏÈÉú medical students matched into 22 different specialties for residency. Twenty-one percent elected to stay within the ºÃÉ«ÏÈÉú HealthCare system, and an additional nine percent elected to stay in Kentucky for residency.
On Oct. 17, the Lexington Convention Center teemed with more than 200 students and scientists sharing their latest research on cardiovascular health for the 17th annual Gill Heart Institute Cardiovascular Research Day.
Nigel Mackman, Ph.D., director of the McAllister Heart Institute at the University of North Carolina at Chapel Hill, presented "Hematosis, Thrombosis and Immunity," demonstrating the diverse roles of hemostasis and thrombosis in cardiovascular diseases, cancers and infections. Kathryn J.
The University of Kentucky Board of Trustees Saturday adopted a sweeping statement of principles, directing President Eli Capilouto to focus on the "most pressing" needs of Kentucky by determining how best to grow ºÃÉ«ÏÈÉú's research enterprise through strategic investments in facilities and talent.
"The challenges are overwhelming, but we can be up to the task of making a difference," Capilouto said. "These are not easy issues, but they must be our issues.
A group of University of Kentucky medical students who call themselves the "Sonokittens" have distinguished themselves as the world's savviest student sonographers with a win at the first-ever World Cup of Ultrasound Competition.
The ºÃÉ«ÏÈÉú College of Medicine students who share a special interest in bedside ultrasound competed in the ultimate skills test at the World Congress of Ultrasound in Medical Education, Oct. 10-12 in Portland, Oregon.
The Alzheimer’s Association has awarded a $100,000 New Investigator Research Grant to Jose Abisambra, assistant professor at the University of Kentucky's Sanders-Brown Center on Aging (SBCoA), to study a brain protein that becomes abnormally modified in the course of developing Alzheimer's disease.
The New Investigator Research Grant program is part of the Alzheimer’s Association’s effort to increase the number of scientists conducting Alzheimer’s research by supporting early-career development that will lay the groundwork for future research grants.
After obtaining an undergraduate degree from Vanderbilt University, landing a graduate research position at Georgia Tech, and designing jet engine acoustics as a consultant for the Federal Aviation Administration and NASA, Ben Havrilesko decided to plot a new career course.
Wearing light blue scrubs and toting medical science texts across campus, the first-year medical student is today immersed in the mechanics of the human body. When asked about life before medical school, Havrilesko clarifies some misconceptions about his former role as an aeronautical engineer
Recently, the University of Kentucky family lost an exceptional physician, pioneer and transformational leader for our institution and medical enterprise. Peter Bosomworth, M.D., was 84 when he died Saturday morning, leaving an indelible mark on the University and our mission of quality education, research, health care and service to the Commonwealth of Kentucky.
Dr. Bosomworth was part of the tradition of leadership and quality care that has defined the ºÃÉ«ÏÈÉú medical center for more than 40 years.
The ºÃÉ«ÏÈÉú HealthCare Gill Heart Institute's Cardiac Rehabilitation Program has received recertification from the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR). This certification recognizes the ºÃÉ«ÏÈÉú program for its commitment to improving cardiovascular outcomes and quality of life by enhancing standards of care.
Cardiac rehabilitation programs are designed to help people with cardiovascular events recover more quickly, improve their quality of life and decrease future event rates.
In her research, Sarah D'Orazio, associate professor in the University of Kentucky Department of Microbiology, Immunology and Molecular Genetics, investigates why some people get sicker than others after ingesting the foodborne bacterial pathogen Listeria monocytogenes.
The Sanders-Brown Center on Aging at the University of Kentucky will hold its fourth annual Markesbery Symposium on Aging and Dementia on Friday and Saturday, Nov. 21-22.
The Markesbery Symposium is named in honor of the late Dr. William R. Markesbery, founder and long-time director of the ºÃÉ«ÏÈÉú Sanders-Brown Center on Aging and an internationally renowned expert on aging and dementia.
More than 5 million Americans have Alzheimer's disease (AD) today and millions more are affected by their role as family member, friend or caregiver to those with memory loss.
We've strayed far from the Dr. Marcus Welby persona -- in popular television, at least. But even Dr. Gregory House, the irascible main character in the Fox television drama, has moments of compassion.
In real life, compassion is still very much an important part of a physician's practice. And there is perhaps no clearer example of a physician's need for compassion than in the treatment of headaches.
Off the top of her head, Kaylee Brown can think of 10 girls at her high school who are pregnant. One of them is her younger brother's age, and he's only 14.
But when asked about her priorities, 16-year-old Kaylee doesn't mention dating or boys. Wearing a swing purse and a denim shirt during an appointment with Dr. Hatim Omar at the University of Kentucky Adolescent Care Clinic, Brown talks about assuming a leadership role with her Future Farmers of America chapter, playing on her high school volleyball team and making good grades in her advanced-level classes.
There is a phone call Point of Care Ultrasound Director and Assistant Emergency Medicine Program Director Dr. Matthew Dawson will never forget.
While he was a medical resident in Utah, his father Stewart Dawson, then the chaplain for theLexington Fire Department, called to ask him about a bispectral index monitor – more commonly called a BIS monitor.
Two independent groups of researchers led by Sidney "Wally" Whiteheart, PhD, at the University of Kentucky, and Dr. Charles Lowenstein, at the University of Rochester, have published important studies exploring the role that a gene called STXBP5 plays in the development of cardiovascular disease.
According to Whiteheart, previous genome-wide association studies (GWAS) identified a gene called STXBP5 as a factor that regulates a protein called Von Willebrand factor (VWF).
VWF is an important contributor to normal blood clotting.
The ºÃÉ«ÏÈÉú College of Medicine has launched a new systems-based curriculum that integrates basic science and clinical concepts early in medical school through interactive instructional methods. Want to know what our medical students are saying about these new curricular enhancements? Watch this brief video.
A new study by University of Kentucky researchers has identified a novel molecule named Arylquin 1 as a potent inducer of Par-4 secretion from normal cells. Par-4 is a protein that acts as a tumor suppressor, killing cancer cells while leaving normal cells unharmed.
Normal cells secrete small amounts of Par-4 on their own, but this amount is not enough to kill cancer cells.
